Roche reveals promising results for Vabysmo in treating eye diseases, showcasing significant vision improvements and safety ...

Neurologist Dr. Priyanka Sehrawat advises against ignoring certain headaches, as they could signal serious underlying issues.

K8 was found to reduce geographic atrophy lesion area growth by more than 50% in its first human clinical trial of the drug.

X, the largest long-term extension trial in wet AMD, disease control and durability were maintained over 4 years, with nearly ...

X, the largest long-term extension trial in nAMD, disease control and durability were maintained over 4 years, with nearly 80% of patients on extended dosing by study end1Over 60% of people with a ...

* Treatments vary but may include medications and therapies customized to each person's symptoms and underlying cause ...

A woman in the Netherlands experienced a rare neurological condition that made human faces appear reptilian, with dragon-like features. The case, recently detailed in the journal The Lancet Neurology, ...

INDICATION LEQEMBI ® is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment (MCI) or mild dementia stage of ...

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat ...